Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity1
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
For a given body mass index (BMI), mortality is higher in patients with central compared to generalized obesity. Glucocorticoids play an important role in determining body fat distribution, but circulating cortisol concentrations are reported to be normal in obese patients. Our recent studies show enhanced conversion of inactive cortisone (E) to active cortisol (F) through the expression of 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in cultured omental adipose stromal cells; the autocrine production of F may be a crucial factor in the pathogenesis of central obesity. We have now analyzed F metabolism in subjects with BMIs between 20-25 kg/m2 (group A), 25-30 kg/m2 (group B), and more than 30 kg/m2 (group C; n 12 in each group; six males and six premenopausal females; aged 23-44 yr). Glucose/insulin were measured using a 75-g oral glucose tolerance test, and each subject had total body and regional fat (scapular, waist, hip, and thigh) quantified using dual energy x-ray absorptiometry. Urinary total F metabolites (measured by gas chromatography/mass spectrometry) were increased in subjects with obesity [group A, 11,176 +/- 1,530 microg/24 h (mean +/- SE); group C, 13,661 +/- 1,444], although not significantly so (P = 0.08). There was a significant reduction in the urinary tetrahydrocortisol (THF) +/- 5alpha-THF/tetrahydrocortisone (THE) and the cortol/cortolone ratio in obesity (group A vs. C, 1.06 +/- 0.08 vs. 0.84 +/- 0.04 and 0.41 +/- 0.03 vs. 0.34 +/- 0.03, respectively; both P < 0.05). Urinary free F (UFF) excretion was similar in all three groups, as was the UFF/urinary free E (UFE) ratio. The 0900 h circulating F, E, and ACTH pre- and postovernight 1-mg dexamethasone suppression values were similar in all three groups, but a reduction in the generation of serum F from dexamethasone-suppressed values after oral cortisone acetate (25 mg) was evident in both obese groups [e.g. 546 +/- 37 nmol/L in group A vs. 412 +/- 40 in group B (P < 0.05) and 388 +/- 38 in group C (P < 0.01) 180 min post-E]. Insulin resistance was present in groups B and C, but regression analysis revealed no relationship between F metabolites or the THF +/- 5alpha-THF/THE ratio and insulin action (homeostasis model assessment analysis and insulin values in the oral glucose tolerance test). There was, however, a highly significant relationship between the THF +/- 5alpha-THF/THE ratio and BMI (t = -3.44; P < 0.01) and total body fat (t = -2.27; P < 0.05). Stepwise regression analyses indicated an inverse relationship between THF+/-5alpha-THF/THE and scapular and waist fat (t = -2.25; P = 0.03) and a direct relationship with hip and thigh fat (t = 2.42; P = 0.02) in both sexes. The fall in the THF + 5alpha-THF/THE ratio but unchanged UFF/UFE ratio together with impaired F concentrations after oral E indicates inhibition of 11betaHSD1 in subjects with obesity. This results in an increased MCR for F, explaining the increased F secretion rate in obesity in the face of normal circulating F concentrations. 11BetaHSD1 activity is highly related to body fat distribution, with android or central obesity, but not gynoid obesity, associated with reduced activity in both sexes. This reduction in 11betaHSD1 activity raises new questions as to the primary role of 11betaHSD1 in the pathogenesis of insulin resistance and central obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As surrogate measures of adverse metabolic risk (27), AVF and omental fat-cell size have been associated in some but not all studies with increased activity or expression of 11β-hydroxysteroid dehydrogenase type 1, which promotes conversion of inactive cortisone to active cortisol (28–31).”
From Glucose ingestion selectively amplifies ACTH and cortisol secretory-burst mass and enhances their joint synchrony in healthy men. (2011) · cites this paper as [31]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 2×
“increased expression of 11bHSD1 in human adipose stromal cells from omental compared with sc depots (21).”
Self-citationSex- and menopause-associated changes in body-fat distribution
Ley, C., Lees, B., & Stevenson, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.5.950 · Cited by 733
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
(1996) · PubMed · Cited by 643
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cortisol secretion in relation to body fat distribution in obese premenopausal women
Mårin, P., Darin, N., Amemiya, T., Andersson, B., Jern, S., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90171-6 · Cited by 458
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Self-citationPasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate, A. M., & Barbara, L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8393881 · Cited by 366
Obesity and Gender Influence Cortisol Secretion and Metabolism in Man
Andrew, R., Phillips, D. I. W., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1806 · Cited by 360
Jamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Walker, B. R. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3155 · Cited by 277
Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00853.x · Cited by 276 · cited 2×
“There was no change in the UFF/UFE ratio between groups, suggesting similar levels of 11bHSD2 (23) (Fig.”
Self-citationShams, M., Kilby, M. D., Somerset, D. A., Howie, A. J., Gupta, A., Wood, P. J., Afnan, M., & Stewart, P. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.799 · Cited by 276 · cited 1×
“E was analyzed by RIA, using antiserum N-137 and 21-acetyl-cortisone-3CMO-histamine[125I] tracer, as previously reported ( 25 ).”
Self-citationMuscle and Adipose Tissue Morphology and Metabolism in Cushing’s Syndrome*
REBUFFÉ-SCRIVE, M., KROTKIEWSKI, M., ELFVERSON, J., & BJÖRNTORP, P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1122 · Cited by 266
Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
Shackleton, C. H. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90132-g · Cited by 247 · cited 1×
“In addition, a urinary steroid metabolite profile was analyzed, using gas chromatography/mass spectrometry, as previously reported (22, 23), measuring free and conjugated F metabolites.”
Self-citationEndocrine function in human obesity
Glass, A. R., Burman, K. D., Dahms, W. T., & Boehm, T. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90224-9 · Cited by 233
STUDY OF ADRENOCORTICAL FUNCTION IN OBESITY.
Migeon, C. J., GREEN, O. C., & Jp, E. (1963) · PubMed · Cited by 224
Ljung, T., Andersson, B., Bengtsson, B., Björntorp, P., & Mårin, P. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00546.x · Cited by 200
Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1
Ricketts, M. L., Verhaeg, J. M., Bujalska, I., Howie, A. J., Rainey, W. E., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4706 · Cited by 197
Self-citationRodin, A., Thakkar, H., Taylor, N., & Clayton, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402173300703 · Cited by 192
Stewart, P. M., Wallace, A. M., Atherden, S. M., Shearing, C. H., & Edwards, C. R. W. (1990) · Clinical Science · doi:10.1042/cs0780049 · Cited by 187
Self-citationWhorwood, C. B. (1993) · Endocrinology · doi:10.1210/en.132.6.2287 · Cited by 178
Self-citationRajan, V, Edwards, C., & Seckl, Jr. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00065.1996 · Cited by 171
Mayo-Smith, W., Hayes, C. W., Biller, B. M., Klibanski, A., Rosenthal, H., & Rosenthal, D. I. (1989) · Radiology · doi:10.1148/radiology.170.2.2911678 · Cited by 169
Monder, C., Miroff, Y., Marandici, A., & Hardy, M. P. (1994) · Endocrinology · doi:10.1210/en.134.3.1199 · Cited by 154
HAMMAMI, M. M., & SIITERI, P. K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-326 · Cited by 124
Michael, A. E., Pester, L. A., Curtis, P., Shaw, R. W., Edwards, C. R. W., & Cooke, B. A. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02147.x · Cited by 110
Cortisol Metabolism in Obesity
DUNKELMAN, S. S., FAIRHURST, B., PLAGER, J., & WATERHOUSE, C. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-9-832 · Cited by 85
HAUTANEN, A., & ADLERCREUTZ, H. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00779.x · Cited by 83
Apparent cortisone reductase deficiency: a unique form of hypercortisolism
Phillipov, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3855 · Cited by 83
Self-citation11β‐Hydroxysteroid dehydrogenase: implications for clinical medicine
Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.716535.x · Cited by 82
Self-citationRicketts, M., Shoesmith, K., Hewison, M., Strain, A., Eggo, M., & Stewart, P. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560159 · Cited by 80
Self-citationA new defect in the peripheral conversion of cortisone to cortisol
Phillipou, G., & Higgins, B. (1985) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(85)90451-0 · Cited by 79
Intercomparison of Four Methods for Measuring Cortisol Production
ZUMOFF, B., FUKUSHIMA, D. K., & HELLMAN, L. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-2-169 · Cited by 69
Weaver, J. U., Taylor, N. F., Monson, J. P., Wood, P. J., & Kelly, W. F. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00494.x · Cited by 66
Rodin, A., Thakkar, H., Taylor, N., & Clayton, R. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199407000-00021 · Cited by 49
Yang, K., Khalil, M. W., Strutt, B. J., & KILLINGER, D. W. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00187-2 · Cited by 48
Influence of thyroid function on the in vivo cortisol ⇌ cortisone equilibrium in man
Zumoff, B., Bradlow, H. L., Levin, J., & Fukushima, D. K. (1983) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(83)90062-6 · Cited by 46
Tissue specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase gene expression
Whorwood, C. B., Sheppard, M. C., & Stewart, P. M. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90180-5 · Cited by 28
Self-citationStreeten, D. H. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.2.8345038 · Cited by 16
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
“In obesity global 11b-HSD1 activity, as measured by urinary corticosteroid metabolite analysis, is impaired [86,87], while selective 11bHSD1 inhibitors, are in development with promising results showing improvements in metabolic profile in rodents [88].”
Method11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“Some studies have described decreased ratios consistent with decreased 11 -HSD1 reductase activity with increasing body mass index (BMI) in simple obesity (140, 203).”
Self-citationSeckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Obesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Metadata
- Authors
- Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- National Health Service (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03
- Volume
- 84
- Issue
- 3
- Pages
- 1022-1027
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2165935278
- Cited by
- 398
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 11 · 2019: 4 · 2018: 3 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 18 · 2013: 10 · 2012: 19
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- cortisol metabolism, abdominal obesity, cortisone to cortisol conversion, 11β-hydroxysteroid dehydrogenase type 1, urinary free cortisol, dexamethasone suppression, ACTH, body fat distribution, glucocorticoid metabolism, obesity pathogenesis, insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Body Constitution, Cortisone, Female, Humans, Hydrocortisone, Male, Obesity, Tetrahydrocortisol, Tetrahydrocortisone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.